Novo Nordisk A/S (NVO)
44.39
-0.68
(-1.51%)
USD |
NYSE |
May 21, 16:00
44.39
0.00 (0.00%)
After-Hours: 19:59
Novo Nordisk Research and Development Expense (TTM) : 8.079B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AstraZeneca PLC | 14.21B |
| GSK Plc | 9.074B |
| Johnson & Johnson | 14.99B |
| Eli Lilly & Co. | 14.11B |
| Lexicon Pharmaceuticals, Inc. | 58.02M |